Isicom

Levodopa/Carbidopa, the active ingredient in Isicom, is a Levodopa/Carbidopa combination presented as an oral tablet for oral use. It is employed to manage the motor symptoms of Parkinson's disease and related Parkinsonian syndromes in adult patients.

GNH USA supplies Isicom as a licensed, GDP‑compliant international pharmaceutical product, sourced from the European Union, and distributes it to hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and regulatory requirements to ensure product integrity.

Isicom (levodopa/carbidopa) is used in the management of Parkinsonian disorders, targeting dopaminergic pathways.

- Parkinson's disease: improves motor function, reduces rigidity and tremor. - Parkinsonian syndrome: alleviates bradykinesia and improves gait stability. - Levodopa‑responsive Parkinsonism: restores dopamine levels to control symptoms.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Orthostatic hypotension: dizziness upon standing. - Headache: transient cranial discomfort. - Insomnia: difficulty initiating sleep. - Dyspepsia: indigestion or stomach discomfort. - Dry mouth: reduced salivation.

Serious or Rare Side Effects: - Dyskinesia: involuntary, erratic movements. - Hallucinations: visual or auditory disturbances. - Severe hypotension: marked drop in blood pressure. - Cardiac arrhythmias: irregular heart rhythms. - Neuroleptic malignant syndrome: rare but life‑threatening reaction. - Severe psychiatric symptoms: agitation or psychosis.

Before initiating therapy, clinicians should consider several safety aspects.

- Blood pressure monitoring: watch for orthostatic changes. - Renal and hepatic function: assess before dose adjustments. - Abrupt discontinuation: avoid sudden stop to prevent withdrawal. - Elderly patients: start with lower doses due to increased sensitivity. - Narrow‑angle glaucoma: use with caution as it may exacerbate intra‑ocular pressure. - Store at ambient temperature: keep in the original pack, protect from moisture.

Levodopa/carbidopa can interact with several medicines, requiring careful management.

Major Interactions (Avoid): - Non‑selective MAO inhibitors: risk of hypertensive crisis. - Pyridoxine (vitamin B6) high doses: may reduce levodopa efficacy. - Antipsychotics (dopamine antagonists): can block therapeutic effect.

Moderate Interactions (Monitor Closely): - Antihypertensives: may enhance orthostatic hypotension. - SSRIs and SNRIs: potential for serotonin syndrome. - Iron or calcium supplements: may impair levodopa absorption. - Other Parkinsonian agents: dose adjustments may be needed.